Multiple myeloma

Multiple myeloma is a rare but serious cancer of the plasma cells that occurs in cats. Plasma cells are specialized white blood cells that originate in the bone marrow and play a crucial role in the immune system by producing antibodies to fight infections. When these cells become cancerous, they multiply uncontrollably within the bone marrow, eventually crowding out healthy blood cells and causing a cascade of health problems throughout the body. Although relatively uncommon compared to other feline cancers, multiple myeloma represents a significant health concern when it does occur, primarily affecting older cats typically over ten years of age.

The underlying cause of multiple myeloma involves the malignant transformation of plasma cells, though the exact triggers for this transformation remain poorly understood in veterinary medicine. The cancerous plasma cells proliferate within the bone marrow and often produce excessive amounts of a single type of antibody protein, known as a monoclonal protein or M-protein. This abnormal protein production can lead to various complications including kidney damage, increased blood viscosity, and interference with normal immune function. The disease typically develops gradually, with cancer cells slowly accumulating over time before clinical signs become apparent.

Multiple myeloma significantly impacts a cat's overall health and quality of life through multiple mechanisms. The proliferation of cancerous plasma cells within the bone marrow can suppress normal blood cell production, leading to anemia, increased susceptibility to infections, and bleeding disorders. Additionally, the abnormal proteins produced by myeloma cells can damage vital organs, particularly the kidneys. Bone lesions may develop as the cancer erodes skeletal tissue, causing pain and increasing the risk of pathological fractures. Cat owners should be aware of this condition because early recognition of symptoms can lead to earlier intervention and potentially better outcomes.

While multiple myeloma is not curable in cats, it is often treatable with appropriate veterinary care aimed at controlling the disease and maintaining quality of life. Treatment typically involves chemotherapy protocols designed to reduce the population of cancerous plasma cells and manage associated complications. Early detection through regular veterinary examinations and prompt investigation of concerning symptoms can improve the chances of successful disease management. Working closely with a veterinarian or veterinary oncologist is essential for developing an appropriate treatment plan and monitoring the cat's response to therapy throughout the course of the disease.

The primary cause of multiple myeloma in cats is the malignant transformation of plasma cells within the bone marrow, though the specific factors that trigger this transformation are not fully understood. Plasma cells are the mature form of B lymphocytes, white blood cells responsible for producing antibodies as part of the immune response. In multiple myeloma, a single plasma cell undergoes genetic mutations that cause it to divide uncontrollably, eventually forming a clone of identical cancerous cells. These malignant plasma cells accumulate in the bone marrow and may spread to other sites throughout the body, disrupting normal physiological functions.

Genetic and hereditary factors in feline multiple myeloma have not been well characterized, and no specific breed predispositions have been definitively established in cats. Unlike some canine cancers that show clear breed associations, multiple myeloma appears to occur sporadically across all cat breeds and mixed-breed cats. However, the disease does show a strong age association, with the vast majority of cases occurring in cats over eight years of age, suggesting that accumulated cellular damage over time may contribute to the development of cancerous mutations. Family history studies in cats are limited, but there is no current evidence of hereditary transmission patterns.

Environmental and lifestyle factors that might contribute to multiple myeloma development in cats remain largely unknown. Some researchers have speculated about potential links to chronic immune stimulation, viral infections, or exposure to environmental carcinogens, but definitive evidence supporting these theories is lacking in veterinary literature. Unlike some other feline cancers where viral causes have been identified, no specific infectious agent has been linked to multiple myeloma in cats. Chronic inflammation and persistent antigenic stimulation have been proposed as possible contributing factors, as these conditions can lead to prolonged plasma cell activation.

Risk factors for multiple myeloma in cats primarily center on advanced age, with most affected cats being senior or geriatric patients. The accumulation of genetic mutations over a cat's lifetime may increase the likelihood of a plasma cell undergoing malignant transformation. Cats with compromised immune systems or those with chronic inflammatory conditions may theoretically be at increased risk, though this has not been proven. Pre-existing conditions affecting the bone marrow or immune system could potentially predispose cats to developing plasma cell tumors, but specific associations have not been established in veterinary research.

The mechanism by which multiple myeloma develops involves a complex series of genetic alterations within a single plasma cell that confer growth advantages and immortality. The transformed cell begins to divide repeatedly, eventually establishing a population of identical malignant cells. These myeloma cells produce large quantities of a single type of antibody protein, which accumulates in the blood and can cause hyperviscosity syndrome. The expanding population of cancer cells within the bone marrow crowds out normal hematopoietic cells, leading to cytopenias affecting red cells, white cells, and platelets. Additionally, myeloma cells secrete factors that stimulate bone breakdown by osteoclasts, resulting in the characteristic bone lesions and hypercalcemia seen in many affected cats.

Early warning signs of multiple myeloma in cats are often subtle and nonspecific, making early detection challenging for even attentive cat owners. Cats are naturally adept at masking illness, and the gradual onset of multiple myeloma symptoms means that changes may be dismissed as normal aging. Initial signs may include slight decreases in activity level, reduced appetite, or minor weight loss that develops over weeks to months. Some cats may show increased thirst and urination as one of the earliest manifestations, particularly if kidney function is being affected by the abnormal proteins produced by myeloma cells. Owners may notice their cat sleeping more than usual or being less interested in play and interaction.

Common symptoms of multiple myeloma in cats reflect the multisystem nature of this disease and can vary considerably between individual patients. Lethargy and weakness are frequently reported, often resulting from anemia caused by the crowding out of normal red blood cell production in the bone marrow. Weight loss despite maintaining or even increasing food intake is another common finding, as the metabolic demands of the cancer and associated complications take their toll on the body. Many cats develop increased thirst and urination, which may indicate kidney involvement or elevated blood calcium levels. Some owners report that their cats seem painful or reluctant to move, which may reflect bone involvement or generalized malaise.

Behavioral changes associated with multiple myeloma can provide important clues to observant cat owners. Affected cats often become less active and may spend more time resting in quiet, secluded locations. Changes in social behavior may be noted, with previously affectionate cats becoming withdrawn or irritable. Appetite fluctuations are common, with some cats showing decreased interest in food while others may eat more in an attempt to compensate for the disease's metabolic effects. Litter box habits may change, particularly if the cat is producing more urine due to kidney issues or hypercalcemia, and some cats may have accidents outside the box due to increased urgency or weakness.

Physical signs that may be observed in cats with multiple myeloma include pale gums indicating anemia, visible weight loss with muscle wasting, and occasionally palpable masses or areas of bone tenderness. The cat's coat may lose its luster and become unkempt as grooming decreases. In some cases, owners may notice bleeding tendencies such as prolonged bleeding from minor wounds, blood in the urine or stool, or unexplained bruising. Enlarged lymph nodes or an enlarged spleen may be detected during physical examination. Some cats develop swelling in the limbs or face due to hyperviscosity of the blood affecting circulation.

Symptom progression in multiple myeloma typically follows a pattern of gradual worsening as the disease advances and complications develop. Early in the disease course, symptoms may wax and wane, with cats having good days and bad days. As the cancer progresses, symptoms generally become more persistent and severe. Anemia worsens, leading to increased weakness and exercise intolerance. Bone lesions may progress to the point where pathological fractures occur with minimal trauma. Kidney function may deteriorate further, contributing to nausea, vomiting, and additional weight loss. The timeline of progression varies considerably between cats, with some experiencing rapid decline and others maintaining relatively stable disease for extended periods.

Emergency symptoms requiring immediate veterinary attention include sudden collapse or extreme weakness, difficulty breathing, severe bleeding that does not stop, inability to stand or walk, complete loss of appetite lasting more than 24 hours, and signs of severe pain such as crying out or aggressive behavior when touched. Sudden hind limb paralysis can occur if the spine is affected by bone lesions or if hyperviscosity affects spinal cord blood flow. Seizures or sudden changes in mental status may indicate that abnormal proteins are affecting brain function. Any sudden deterioration in a cat known to have multiple myeloma should be treated as an emergency, as complications can progress rapidly and require immediate intervention to prevent death.

The initial veterinary examination for suspected multiple myeloma begins with a comprehensive physical assessment and detailed history taking. The veterinarian will ask about the duration and progression of symptoms, any changes in appetite, water consumption, urination habits, and activity level. Physical examination may reveal pale mucous membranes suggesting anemia, enlarged lymph nodes or spleen, areas of bone pain or swelling, and general signs of illness such as dehydration or poor body condition. The veterinarian will also assess the cat's neurological status, as multiple myeloma can occasionally affect the nervous system. Based on physical findings and clinical suspicion, the veterinarian will recommend appropriate diagnostic testing.

Diagnostic tests for multiple myeloma in cats typically include a comprehensive blood panel encompassing complete blood count, serum chemistry profile, and urinalysis. The complete blood count often reveals anemia, which may be moderate to severe depending on disease stage, and may show decreased platelet counts or abnormal white blood cell numbers. Serum chemistry may demonstrate elevated total protein levels with abnormal protein patterns, increased calcium levels, and evidence of kidney dysfunction with elevated BUN and creatinine. A specialized test called serum protein electrophoresis is crucial for identifying the characteristic monoclonal protein spike produced by myeloma cells. Urinalysis may reveal protein in the urine, specifically Bence Jones proteins which are light chain fragments produced by myeloma cells. Imaging studies including radiographs and potentially CT scans help identify the characteristic punched-out bone lesions associated with multiple myeloma.

Differential diagnosis for multiple myeloma includes other conditions that can cause similar clinical signs and laboratory abnormalities. Other types of cancer affecting the bone marrow, such as lymphoma, leukemia, or metastatic tumors, must be considered. Chronic kidney disease can cause many similar symptoms and laboratory changes but lacks the monoclonal protein spike. Other plasma cell tumors including plasmacytoma may present similarly but have different distributions. Chronic infections or inflammatory conditions can cause elevated protein levels but typically show a polyclonal rather than monoclonal pattern. Immune-mediated diseases affecting blood cells may cause cytopenias similar to those seen in myeloma. Accurate differentiation requires careful evaluation of all diagnostic findings.

Definitive diagnosis of multiple myeloma requires demonstration of specific criteria, typically including identification of a monoclonal protein spike on serum electrophoresis, presence of plasma cell infiltration in the bone marrow documented through bone marrow aspiration and biopsy, and evidence of end-organ damage such as bone lesions, kidney dysfunction, or hypercalcemia. Bone marrow examination is essential and involves collecting a sample of marrow, usually from the hip or shoulder, for cytological and histopathological evaluation. Finding greater than 20 percent plasma cells in the marrow, particularly with atypical morphology, supports the diagnosis. Once diagnosis is confirmed, staging may be performed to assess the extent of disease spread and guide treatment planning. Results from diagnostic testing are typically available within several days, and the veterinarian or veterinary oncologist will discuss findings and treatment options with the cat's owner.

Emergency and immediate treatment for cats diagnosed with multiple myeloma focuses on stabilization and addressing life-threatening complications before initiating definitive cancer therapy. Cats presenting with severe anemia may require blood transfusions to restore oxygen-carrying capacity and improve tissue oxygenation. Those with dangerous elevations in blood calcium require aggressive intravenous fluid therapy to promote calcium excretion through the kidneys and dilute calcium concentrations in the blood. If hyperviscosity syndrome is present, causing signs such as bleeding, neurological abnormalities, or cardiac problems, plasmapheresis may be considered to remove excess proteins from the blood, though this is available only at specialized centers. Pain management is initiated for cats showing signs of bone pain or discomfort.

Medical management of multiple myeloma in cats centers on chemotherapy protocols designed to reduce the population of malignant plasma cells. The most commonly used chemotherapy drug for feline multiple myeloma is melphalan, an alkylating agent that has shown efficacy in controlling the disease. Melphalan is typically administered orally at home on an intermittent schedule, making it relatively convenient for long-term use. Prednisone, a corticosteroid, is often used in conjunction with melphalan to enhance effectiveness and provide additional anti-cancer and anti-inflammatory benefits. The combination of melphalan and prednisone can often achieve partial or complete remission, with reduction in abnormal protein levels and improvement in clinical signs. Treatment is generally continued long-term, with regular monitoring to assess response and watch for side effects.

Surgical options for multiple myeloma are limited because this is a systemic disease involving the bone marrow throughout the body. However, surgery may play a role in specific situations. If a solitary plasmacytoma is present without evidence of systemic myeloma, surgical excision followed by radiation therapy may be curative. Orthopedic surgery may be necessary to stabilize pathological fractures caused by bone lesions, improving comfort and mobility. In some cases, biopsy procedures are performed surgically to obtain tissue samples for diagnosis when less invasive methods are insufficient. Any surgical procedures must be carefully planned in cats with myeloma due to potential complications from anemia and bleeding tendencies.

Supportive care is a crucial component of multiple myeloma management and addresses the various complications and quality of life issues associated with the disease. Nutritional support ensures adequate caloric intake through highly palatable, energy-dense diets and may include appetite stimulants if needed. Fluid therapy, either intravenous or subcutaneous, helps maintain hydration and supports kidney function. Pain management utilizing appropriate analgesics ensures comfort, particularly for cats with bone involvement. Anti-nausea medications may be prescribed if chemotherapy or the disease itself causes gastrointestinal upset. Antibiotics may be needed to treat or prevent infections in immunocompromised patients.

Alternative and complementary treatments may be considered as adjuncts to conventional therapy for multiple myeloma, though their efficacy has not been proven in controlled veterinary studies. Acupuncture may provide pain relief and improve overall well-being in some cats. Nutritional supplements including omega-3 fatty acids may have anti-inflammatory benefits and support overall health. Some owners explore traditional Chinese veterinary medicine or herbal therapies, which should only be used under veterinary guidance to avoid interactions with conventional treatments. Physical therapy and massage may help maintain mobility and comfort in cats with bone involvement. These approaches should complement rather than replace evidence-based conventional treatment.

Treatment decisions for multiple myeloma involve careful consideration of multiple factors including the cat's overall health status, age, disease stage, and the owner's goals and resources. Chemotherapy can effectively control the disease in many cats but requires commitment to regular medication administration and monitoring visits. The cost of diagnosis, treatment, and ongoing monitoring can be substantial, and owners should discuss financial aspects with their veterinary team. Some owners may opt for palliative care focused on comfort rather than aggressive disease management, which is a valid and humane choice. The expected outcome with treatment is typically disease control rather than cure, with many cats achieving good quality of life for months to occasionally years. Without treatment, the prognosis is poor, with most cats surviving only weeks to a few months.

Recovery timeline for cats with multiple myeloma varies significantly depending on disease severity at diagnosis, response to treatment, and individual patient factors. Initial stabilization of acutely ill cats may take days to weeks, during which time supportive care addresses immediate concerns such as anemia, dehydration, and hypercalcemia. Once chemotherapy is initiated, some cats show improvement in clinical signs within the first few weeks of treatment, with increased energy, improved appetite, and better overall demeanor. Laboratory parameters including protein levels and blood counts may take longer to normalize, typically showing gradual improvement over one to three months. The goal of treatment is to achieve remission, which may be partial or complete, and maintain it for as long as possible.

Post-treatment care for cats with multiple myeloma involves ongoing medication administration, regular monitoring, and attention to quality of life. Owners will need to administer oral chemotherapy medications at home according to the prescribed schedule, handling these drugs carefully as they can be hazardous. Regular veterinary visits, typically every few weeks to monthly initially, allow for physical examination and blood work to monitor disease status and watch for treatment side effects. Activity restrictions are generally not necessary unless bone lesions create risk of pathological fractures, in which case controlled activity and prevention of jumping may be recommended. Follow-up imaging may be performed periodically to assess bone lesion status.

Prognostic factors for multiple myeloma in cats include the extent of disease at diagnosis, response to initial treatment, and development of complications. Cats presenting with severe anemia, significant kidney dysfunction, or widespread bone lesions generally have a more guarded prognosis than those with early-stage disease. Response to chemotherapy is an important prognostic indicator, with cats achieving remission typically surviving longer than those who fail to respond. The level of monoclonal protein and how quickly it decreases with treatment can also predict outcomes. Despite treatment, most cats with multiple myeloma eventually experience disease progression, though the timeline is variable and some cats maintain good quality of life for extended periods.

Long-term outlook for cats with multiple myeloma is guarded but not hopeless, as many cats respond favorably to treatment and enjoy good quality of life for meaningful periods. Median survival times with treatment range from approximately six months to over two years in various studies, with individual variation being substantial. Some cats remain in stable remission for years with ongoing chemotherapy, while others experience earlier relapse. Recurrence of disease is common and may require adjustment of treatment protocols or consideration of additional therapeutic options. Quality of life rather than absolute survival time should be the primary consideration, with the goal being to maximize comfortable, happy time rather than simply extending life. Regular reassessment with the veterinary team helps ensure that treatment goals remain appropriate as the disease evolves.

Primary prevention of multiple myeloma in cats is challenging because the specific causes of this cancer are not well understood, and no modifiable risk factors have been definitively identified. Unlike some cancers where lifestyle factors play clear roles, there are no proven strategies to prevent plasma cell tumors from developing. However, general measures that support overall health and immune function may theoretically reduce cancer risk. Maintaining cats at a healthy body weight, providing balanced nutrition, minimizing exposure to known carcinogens including tobacco smoke, and reducing chronic stress may all contribute to overall health resilience. While these measures cannot guarantee prevention of multiple myeloma, they support general wellbeing and may reduce the risk of various health problems.

Environmental prevention considerations focus on minimizing exposure to potential carcinogens and maintaining a healthy living environment for cats. Keeping cats indoors reduces exposure to outdoor environmental toxins, infections, and trauma. Avoiding the use of pesticides, herbicides, and other chemicals in areas where cats live may reduce potential carcinogen exposure. Providing clean, fresh water and high-quality food supports overall health. Maintaining good air quality by avoiding smoking indoors and using air filtration can benefit respiratory and overall health. While none of these measures specifically prevent multiple myeloma, they contribute to a healthier environment that may support cancer resistance.

Dietary prevention strategies for multiple myeloma are not established, but nutrition plays an important role in maintaining immune function and overall health. Feeding high-quality commercial cat foods that meet nutritional requirements ensures adequate intake of essential nutrients. Some evidence suggests that antioxidants may support cellular health and reduce oxidative damage that could contribute to cancer development, though specific recommendations for cancer prevention are not established in cats. Avoiding obesity through appropriate caloric intake may be beneficial, as obesity has been linked to increased cancer risk in some species. Omega-3 fatty acids have anti-inflammatory properties and may support immune function. Consultation with a veterinarian can help determine the best nutritional approach for individual cats.

Health maintenance through regular veterinary care represents the most practical approach to early detection and management of multiple myeloma. Annual wellness examinations for adult cats and twice-yearly examinations for senior cats allow veterinarians to detect subtle changes that may indicate developing health problems. Routine blood work, including complete blood counts and chemistry panels, can identify abnormalities suggestive of blood cell cancers or other conditions. Maintaining current vaccinations protects against infectious diseases that could stress the immune system. Parasite prevention reduces chronic inflammatory stimuli. Dental care prevents oral infections and systemic inflammation. These regular health maintenance activities create opportunities for early detection of abnormalities.

Early intervention when abnormalities are detected offers the best opportunity for successful management of multiple myeloma. Cat owners should promptly report any changes in their cat's behavior, appetite, water consumption, activity level, or physical condition to their veterinarian. Vague signs such as lethargy, weight loss, or increased thirst should not be dismissed, as these may indicate serious underlying conditions including cancer. Senior cats especially should be monitored closely for changes that could signal health problems. When blood work or other tests reveal abnormalities, following up with additional diagnostics rather than taking a wait-and-see approach can lead to earlier diagnosis. Early detection of multiple myeloma, while the disease burden is still relatively low, may allow for more effective treatment and better outcomes.

Daily management of a cat with multiple myeloma requires attention to medication administration, monitoring, and quality of life maintenance. Owners must administer prescribed chemotherapy medications consistently and safely, following handling precautions for cytotoxic drugs including wearing gloves and avoiding crushing tablets. Keeping a medication log helps ensure doses are not missed and provides useful information for veterinary visits. Daily observation of the cat's appetite, energy level, water consumption, and urination patterns helps identify changes that may indicate disease progression or treatment complications. Establishing routines for medication times and monitoring activities makes management more manageable and less likely to be overlooked.

Home environment modifications can significantly improve comfort and safety for cats living with multiple myeloma. Providing soft, easily accessible bedding in quiet locations allows for restful sleep without needing to jump to high surfaces. If bone lesions are present, removing opportunities for jumping by providing ramps or steps to favorite spots reduces fracture risk. Litter boxes should be easily accessible with low sides if mobility is compromised, and multiple boxes throughout the home reduce the distance the cat needs to travel. Maintaining a calm, stress-free environment supports overall wellbeing, which may mean creating quiet spaces away from household commotion. Temperature regulation through comfortable bedding and appropriate room temperatures helps cats who may have difficulty maintaining body warmth.

Quality of life for cats with multiple myeloma should be assessed regularly and remains the primary focus of disease management. Cats can continue to enjoy many of their favorite activities with appropriate modifications. Gentle play sessions that do not overstress joints or bones provide mental stimulation and maintain the human-animal bond. Grooming assistance may be appreciated if the cat is not grooming effectively due to weakness or malaise. Favorite treats and foods can be offered to encourage eating and provide enjoyment. Environmental enrichment through window perches with easy access, interactive toys, and social interaction supports mental health. The goal is to maximize comfort and happiness while managing the disease.

Ongoing monitoring and regular veterinary care are essential for successful management of multiple myeloma. Veterinary visits every few weeks to monthly allow for physical examination and blood work to track disease status and treatment response. Monitoring serum protein levels through electrophoresis helps assess whether the cancer is controlled, stable, or progressing. Complete blood counts detect anemia, infections, or other complications requiring intervention. Kidney function monitoring through chemistry panels identifies deterioration that may require treatment adjustment. Owners should maintain communication with the veterinary team between scheduled visits, reporting any concerning changes promptly. Adjustments to treatment protocols may be needed based on monitoring results and clinical status.

Caregiver support is an important but often overlooked aspect of managing a cat with cancer. Caring for a pet with a serious illness can be emotionally and financially demanding, and owners should seek support when needed. Veterinary social workers or counselors at some practices can help with emotional aspects of pet illness. Online support groups connect owners of cats with cancer, providing community and shared experiences. Financial planning for ongoing treatment costs helps reduce stress about affording care. Taking breaks and practicing self-care ensures caregivers can continue providing quality care without burnout. Discussing prognosis and quality of life honestly with the veterinary team helps owners make informed decisions and prepares them for the eventual progression of the disease. Knowing when to consider humane euthanasia and understanding the process can reduce anxiety about end-of-life decisions.

Multiple myeloma has not been definitively associated with specific cat breeds, and the condition appears to occur across all breeds and mixed-breed cats without clear predisposition patterns. Unlike some feline cancers that show distinct breed associations, multiple myeloma seems to develop sporadically regardless of genetic background. Domestic shorthair and domestic longhair cats are most commonly diagnosed with multiple myeloma, but this likely reflects the prevalence of these cats in the general population rather than true increased susceptibility. No purebred cat breed has been identified in veterinary literature as having significantly elevated risk for developing plasma cell tumors.

While breed predisposition is not established, certain categories of cats may warrant closer monitoring for multiple myeloma. Age is the most consistent risk factor, with the vast majority of cases occurring in cats over eight years of age and peak incidence in cats ten years and older. Senior cats of all breeds should receive regular wellness examinations and blood work that could detect early signs of this and other age-related conditions. Cats with a history of chronic infections, inflammatory conditions, or immune system abnormalities may theoretically be at increased risk, though this has not been proven. Any cat showing nonspecific signs of illness, particularly older cats, should receive thorough veterinary evaluation.

Screening recommendations for multiple myeloma in cats focus on general senior cat health monitoring rather than breed-specific testing. Annual wellness blood work including complete blood count and chemistry panel is recommended for all cats over seven years of age, with twice-yearly testing advisable for cats over ten. These routine tests can detect elevated protein levels, anemia, and other abnormalities that might suggest multiple myeloma or other blood cell cancers. Serum protein electrophoresis is not typically performed as a screening test but should be pursued if routine testing reveals unexplained elevated protein levels. Cat owners should work with their veterinarians to establish appropriate monitoring schedules based on their individual cat's age and health status.

Conditions that commonly co-occur with multiple myeloma include kidney disease and hypercalcemia, both of which can develop as direct consequences of the cancer. The abnormal proteins produced by myeloma cells can damage kidney tubules and glomeruli, leading to progressive renal dysfunction that may require supportive management including fluid therapy and dietary modification. Elevated blood calcium levels occur when bone lesions release calcium into the bloodstream and can cause additional kidney damage, cardiac abnormalities, and neurological signs. Anemia frequently accompanies multiple myeloma due to bone marrow infiltration by cancer cells and may be severe enough to require transfusion support. Managing these concurrent conditions alongside the primary cancer is essential for maintaining quality of life.

Conditions with similar symptoms to multiple myeloma that must be differentiated through diagnostic testing include lymphoma, leukemia, and other bone marrow cancers. Lymphoma is the most common hematopoietic cancer in cats and can cause similar signs including weight loss, lethargy, and bone marrow involvement, but protein electrophoresis patterns differ. Chronic kidney disease alone can cause many symptoms overlapping with myeloma but lacks the monoclonal protein spike. Immune-mediated hemolytic anemia causes anemia and weakness but has different underlying mechanisms and laboratory findings. Infectious diseases including feline leukemia virus and feline immunodeficiency virus can cause similar clinical pictures and should be ruled out. Accurate diagnosis through comprehensive testing ensures appropriate treatment selection.

Potential complications of multiple myeloma extend beyond the primary disease and require vigilant monitoring. Pathological fractures can occur when bone lesions weaken skeletal structures, causing sudden lameness or inability to walk. Hyperviscosity syndrome develops when blood becomes too thick due to excess proteins, affecting circulation to vital organs including the brain, eyes, and heart. Secondary infections may occur due to immune suppression from both the disease and chemotherapy treatment. Bleeding disorders can develop from platelet dysfunction or low platelet counts. Neurological complications including weakness, incoordination, or seizures may result from hypercalcemia, hyperviscosity, or direct nervous system involvement. Recognizing these complications early and addressing them promptly helps maintain quality of life and may improve survival.